Decibel Therapeutics, a clinical-stage biotechnology company, has established the world’s first comprehensive drug discovery, development, and translational research platform for hearing and balance disorders.

Biotechnology

Decibel Therapeutics

Pete Weber

Courtney Shanks

Bridget Cleff

Elaine Kernbauer

Jeffrey Schulz

The Research and Development team at Decibel Therapeutics is dedicated to advancing innovative therapies for hearing and balance disorders. This multidisciplinary group conducts cutting-edge research, utilizes analytical techniques, and collaborates on clinical operations to translate scientific discoveries into effective treatments, ensuring the safety and efficacy of new drug candidates.

Research and Development

Advisory Team

Leadership Team

Research and Development

About

Team members

Other teams at Decibel Therapeutics

Advisory Team

Leadership Team